Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cyclo Therapeutics, Inc. (CYTH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4800+0.1600 (+6.90%)
At close: 04:00PM EDT
2.8400 +0.36 (+14.52%)
After hours: 07:56PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.3200
Open2.3700
Bid2.0000 x 1100
Ask2.9000 x 800
Day's Range2.2700 - 2.4800
52 Week Range1.8200 - 8.3000
Volume28,002
Avg. Volume20,300
Market Cap20.845M
Beta (5Y Monthly)-0.61
PE Ratio (TTM)N/A
EPS (TTM)-2.8080
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
  • Business Wire

    Cyclo Therapeutics to Present at the China NPC Association Meeting

    GAINESVILLE, Fla., August 08, 2022--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that Lise Kjems, MD, PhD, Chief Medical Officer of Cyclo Therapeutics will present at the 2022 China Nieman Pick Medical Exchange & Sixth Patient Association being held August 13, 2022 in Xiamen, China

  • Business Wire

    Cyclo Therapeutics to Present at the NNPDF-INPDA Conferences 2022

    GAINESVILLE, Fla., July 21, 2022--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that it will participate at the 30th Annual NNPDF Family Support & Medical Conference in conjunction with the INPDA Biennial Meeting being held July 28-31, 2022, in Orlando, FL.

  • Simply Wall St.

    We're A Little Worried About Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Rate

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Advertisement
Advertisement